Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Phenserine Treatment on Amyloid in Brains of Patients with Mild Probable Alzheimer's Disease
2004-001336-22Phase 2Completed
- Sponsor
- Axonyx
- Start
- Aug 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Phenserine tartrate with Placebo / active comparator (2 arms). Primary endpoints: Safety of phenserine tartrate treatment and Effect on brain amyloid load. Started Aug 2004; status: completed.
02
Drugs
phenserine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2004-001336-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001336-22.